Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1988-05-02
1990-04-17
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 8591, A61K 4902, A61K 39395
Patent
active
049178784
ABSTRACT:
The invention discloses improved reagents containing antibodies against stage specific embryonic antigen-1 antibodies and improved methods for detection of occult abscess and inflammation using the improved reagents.
REFERENCES:
patent: 4152410 (1979-05-01), Ishii
patent: 4421735 (1983-12-01), Haber et al.
patent: 4427646 (1984-01-01), Olexa
patent: 4434151 (1984-02-01), Byrne et al.
patent: 4444744 (1984-04-01), Goldenberg
patent: 4460561 (1984-07-01), Goldenberg
patent: 4479930 (1984-10-01), Hnatowich
patent: 4575556 (1986-03-01), Byrne et al.
patent: 4596769 (1986-06-01), Shockman et al.
patent: 4622420 (1986-11-01), Meares et al.
patent: 4634586 (1987-01-01), Goodwin et al.
patent: 4636380 (1987-01-01), Wong
patent: 4647445 (1987-03-01), Lees
patent: 4652519 (1987-03-01), Warshawsky et al.
patent: 4668503 (1987-05-01), Hnatowich
patent: 4671958 (1987-06-01), Rodwell et al.
patent: 4678667 (1987-07-01), Meares et al.
patent: 4707352 (1987-12-01), Stavrianpoulos
patent: 4724212 (1988-02-01), Epstein
patent: 4724213 (1988-02-01), Epstein
Solter, et al., "Monoclonal Antibody Defining a Stage-Specific Mouse Embryonic Antigen", (SSEA-1), Proc. Natl. Acad. Sci., USA, vol. 75, No. 11, pp. 5565-5569, Nov. 1978.
Thakur, et al., Journal of Nuclear Medicine, vol. 18: 1014-1019 (1977).
Thakur, et al., Nucl. Med. Biol., vol. 14: 51-58 (1987).
Thakur, Research in Progress: FY 1986, Summaries of Projects Sponsored by the Office of Health and Environmental Research, Office of Scientific and Technical Information, Jan. 1986.
Richard and Thakur, J. Nucl. Med., vol. 28: Abstract No. 693 (1987).
Thakur, et al., J. Nucl. Med., vol. 28: Abstract No. 419, (1987).
Locher, et al., Nuclear Medicine Communications, vol. 7: 659-670 (1986).
Solter and Knowles, Proc. Nat'l Acad Sci. USA, vol. 75: 5565-5569 (1978).
Fredriksson, et al., Protein A-Sehparase Cl-4B Affinity Purification of IgG Monoclonal Antibodies from Mouse Ascites, S-751 82, Uppsala, Sweden 1985.
De Riemer, et al., J. Labeled Compounds in Radiopharmaceuticals, vol. XVIII: 1517-1534 (1981).
Rodwell, et al., Proc. Nat'l Acad. Sci. USA, vol. 83: 2632-2636.
Meares, et al., Anal. Biochem., vol. 142: 68-78 (1984).
Feldman, Anal. Biochem., vol. 48: 317-338 (1972).
Intenzo, et al., J. Nucl. Med., vol. 28: 438-441 (1987).
Schrothe, Eurp. J. Nucl. Med., vol. 6: 469-472 (1981).
Maples John S.
Thomas Jefferson University
LandOfFree
Novel use of a radiolabelled antibody against stage specific emb does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel use of a radiolabelled antibody against stage specific emb, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel use of a radiolabelled antibody against stage specific emb will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1051331